Preclinical Safety Evaluation of Intraperitoneally Administered Cu-Conjugated Anti-EGFR Antibody NCAB001 for the Early Diagnosis of Pancreatic Cancer Using PET.
Saved in:
| Title: | Preclinical Safety Evaluation of Intraperitoneally Administered Cu-Conjugated Anti-EGFR Antibody NCAB001 for the Early Diagnosis of Pancreatic Cancer Using PET. |
|---|---|
| Authors: | Matsumoto, Hiroki1,2 (AUTHOR), Igarashi, Chika1 (AUTHOR), Tachibana, Tomoko1 (AUTHOR), Hihara, Fukiko1 (AUTHOR), Shinada, Mitsuhiro1,3 (AUTHOR), Waki, Atsuo1 (AUTHOR), Yoshida, Sei4 (AUTHOR), Naito, Kenichiro4 (AUTHOR), Kurihara, Hiroaki2 (AUTHOR), Ueno, Makoto5 (AUTHOR), Ito, Kimiteru6 (AUTHOR), Higashi, Tatsuya1 (AUTHOR), Yoshii, Yukie1,2 (AUTHOR) yoshii.yukie@qst.go.jp |
| Source: | Pharmaceutics. Sep2022, Vol. 14 Issue 9, pN.PAG-N.PAG. 15p. |
| Database: | Academic Search Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| ISSN: | 19994923 |
|---|---|
| DOI: | 10.3390/pharmaceutics14091928 |
